This in vitro study evaluated the effects of magnesium oxide (MgO) nanoparticles on the flexural strength, surface roughness, and color characteristics of a self-cure polymethyl methacrylate (PMMA) provisional crown material. A commercially available PMMA resin was modified with 0.3, 0.5, or 1.0% w/w MgO nanoparticles, while unmodified resin served as the control. A total of 144 specimens were prepared and allocated equally among the four groups for the three outcome assessments. Surface roughness was measured using a contact profilometer, flexural strength was determined using a three-point bending test according to ISO 4049, and color coordinates were recorded using a spectrophotometer in the CIE L*a*b* system. Data were analyzed using the Kruskal–Wallis test followed by Dunn’s post-hoc test with Holm correction. Surface roughness differed significantly among the groups ( p = 0.008), with the 1.0% MgO group exhibiting significantly lower roughness than the control. Flexural strength also differed significantly ( p < 0.001); the 0.5 and 1.0% MgO groups showed significantly higher values than the 0.3% group, while none differed significantly from the control. L* and b* did not differ significantly among the groups, whereas a* showed a significant shift ( p < 0.001). Control-referenced ΔE*ab values derived from the group mean CIELAB coordinates remained below established perceptibility and acceptability thresholds. Within the limitations of this study, 1.0% MgO reduced surface roughness while maintaining flexural strength and overall color characteristics comparable to the control.
No takes yet. Share an insight, caveat, or question.
Kotian et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: